Cabot (NYSE:CBT) Stock Rating Lowered by Wall Street Zen

Cabot (NYSE:CBT) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

A number of other research analysts also recently commented on the company. JPMorgan Chase & Co. increased their target price on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. Truist Financial initiated coverage on Cabot in a research note on Monday, June 8th. They set a “buy” rating and a $98.00 price objective on the stock. UBS Group lifted their price objective on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Finally, Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus price target of $85.80.

Cabot Price Performance

Shares of CBT stock opened at $88.11 on Friday. The firm has a fifty day moving average of $87.89 and a two-hundred day moving average of $79.43. The firm has a market cap of $4.55 billion, a P/E ratio of 16.66, a P/E/G ratio of 11.46 and a beta of 0.84. Cabot has a 1-year low of $58.33 and a 1-year high of $94.53. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, research analysts anticipate that Cabot will post 6.35 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Torren Management LLC acquired a new position in shares of Cabot during the fourth quarter valued at $26,000. Rothschild Investment LLC grew its position in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Global Retirement Partners LLC raised its position in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 466 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Cabot in the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.